These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4546783)

  • 1. Effect of a decarboxylase inhibitor (Ro 4-4602) on 5-HTP induced muricide blockade in rats.
    Bocknik SE; Kulkarni AS
    Neuropharmacology; 1974 Apr; 13(4):279-81. PubMed ID: 4546783
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade of 5-HTp reduction of ethanol drinking with the decarboxylase inhibitor, ro 4-4602.
    Geller I; Hartmann RJ; Messiha FS
    Pharmacol Biochem Behav; 1981 Dec; 15(6):871-4. PubMed ID: 6976579
    [No Abstract]   [Full Text] [Related]  

  • 3. Muricidal block induced by 5-hydroxytryptophan in the rat.
    Kulkarni AS; Rahwan RG; Bocknik SE
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):308-13. PubMed ID: 4541981
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 5-hydroxytryptophan on muricide response induced by thiamine deficiency.
    Onodera K; Kisara K; Ogura Y
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):220-7. PubMed ID: 159673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human sleep and 5-HTP. Effects of repeated high doses and of association with benserazide (RO.04.4602).
    Autret A; Minz M; Bussel B; Cathala HP; Castaigne P
    Electroencephalogr Clin Neurophysiol; 1976 Oct; 41(4):408-13. PubMed ID: 60227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D; Buser P
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract]   [Full Text] [Related]  

  • 7. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
    van Praag HM; Korf J; Lequin RM
    Psychopharmacol Commun; 1976; 2(5-6):369-78. PubMed ID: 1088302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the behavioral effects of 5-HTP by the decarboxylase inhibitor Ro 4-4602.
    Carter RB; Appel JB
    Pharmacol Biochem Behav; 1976 Apr; 4(4):407-9. PubMed ID: 935212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the discriminative stimulus properties of l-5-hydroxytryptophan in the presence of either citalopram or Ro 4-4602.
    Winter JC; Rabin RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):613-6. PubMed ID: 3264918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action L-dopa on sexual behaviour of male rats.
    Da Prada M; Carruba M; Saner A; O'Brien A; Pletscher A
    Brain Res; 1973 Jun; 55(2):383-9. PubMed ID: 4541349
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of administration of 5-hydroxytryptophan and an inhibitor of L-aromatic amino acid decarboxylase on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    Neurochem Res; 1979 Apr; 4(2):277-87. PubMed ID: 313531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent potentiation or inhibition by Ro4-4602 of 5-HTP hyperthermia in rabbits.
    Gardey-Levassort C; Lechat P
    J Pharm Pharmacol; 1974 Apr; 26(4):278-9. PubMed ID: 4151387
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum leptin levels after central and systemic injection of a serotonin precursor, 5-hydroxytryptophan, in mice.
    Yamada J; Ujikawa M; Sugimoto Y
    Eur J Pharmacol; 2000 Oct; 406(1):159-62. PubMed ID: 11011048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice.
    Hyttel J; Fjalland B
    Eur J Pharmacol; 1972 Jul; 19(1):112-4. PubMed ID: 4538041
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Goodale DB; Moore KE
    Life Sci; 1976 Sep; 19(5):701-6. PubMed ID: 957902
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of peripheral mechanisms in the behavioral effects of 5-hydroxytryptophan.
    Carter RB; Dykstra LA; Leander JD; Appel JB
    Pharmacol Biochem Behav; 1978 Aug; 9(2):249-53. PubMed ID: 309609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of firing of raphe neurones by tryptophan and 5-hydroxytryptophan: blockade by inhibiting serotonin synthesis with Ro-4-4602.
    Gallager DW; Aghajanian GK
    Neuropharmacology; 1976 Mar; 15(3):149-56. PubMed ID: 1084488
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans.
    Polleri A; Masturzo P; Murialdo G; Carolei A
    Acta Endocrinol (Copenh); 1980 Jan; 93(1):7-12. PubMed ID: 7355667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide.
    Miñano FJ; Myers RD
    Psychopharmacology (Berl); 1989; 98(2):176-82. PubMed ID: 2502790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.